Board Vitals - Pharmacist

MAY 7, 2022

Almost a year ago now, I became a new mom. Becoming a mom has been transformative, eye opening, beautiful, and of course, a major shock to the system. I did not come from a family with many children or emphasis on children. So, when I brought my son home from the hospital, I barely knew how to change his diaper and my anxiety skyrocketed. Next to learning how to breastfeed, counting down the short time until I went back to work was my greatest stressor.

Hospitals 52

Hospitals 52

Pharma Mirror

MAY 7, 2022

Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.

52

52

Pharma Mirror

MAY 7, 2022

Los Angeles, CA, USA, ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it has signed a new multi-year, non-exclusive supply agreement with Genmab A/S, an international biotechnology company. Under the terms of the agreement, ImaginAb will provide a non-exclusive, worldwide license to Genmab A/S to use its investigational CD8 ImmunoPET imaging technology (

40

40

Pharma Mirror

MAY 7, 2022

Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.

40

40

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Mirror

MAY 7, 2022

Los Angeles, CA, USA, ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it has signed a new multi-year, non-exclusive supply agreement with Genmab A/S, an international biotechnology company. Under the terms of the agreement, ImaginAb will provide a non-exclusive, worldwide license to Genmab A/S to use its investigational CD8 ImmunoPET imaging technology (

40

40